Cord Blood Registry (CBR) is one of the most leading industry dedicated to technical innovations, gives access to current treatments and stem cell application for unstable condition or with no cure. A cord blood bank that passed the standards of cord blood collection and storage regulations made by the U.S. Food and Drug Administration (FDA).
With recent discoveries have shown that the blood in the umbilical cord of a baby contains stem cells that can help treat some conditions, and once removed safely after baby’s birth will be tested to ensure that the required amount is eligible to store in the bank. This is where Cord Bank Registry takes responsibility to store up to ten years and can be retrieve when required for a stem cell treatment.
At this point, CBR has stored over 500,000 cord blood and cord tissue stem cell units and is the leading cord blood bank company recommended by most OB/GYNs and expecting parents. From 3,500 hospitals in over 100 countries, has undergone 17 product upgrades and partnered with institutions to establish FDA-regulated clinical trials, 4 out of 7 clinical trials are still active and recruiting participants.
CBR provides healthcare kit that help increase the collection of cord blood. This CellAdvantage Collection Kit manages a crush-resistant, temperature protected and electronically tracked kit. This kit actively transforms into a cube to encase the blood or tissue collection to ensure its protection and safety. CBR also created an automated and functionally closed stem cell processing technology called AutoExpress Platform.
Cord Blood Registry maintains standards for cellular therapy services through AABB accreditation, FDA-registration, and CLIA certification as well. CBR is found in San Bruno, California and owned 80,000 square foot laboratory located in Tucson, Arizona. It is a registered trademark of Cbr Systems, Inc.